News Novel Contraceptive Nextstellis Gets FDA Approval By Brian Park, PharmD Publish Date April 16, 2021
News FDA Lifts In-Person Dispensing Requirement for Mifepristone During Pandemic By Diana Ernst, RPh Publish Date April 14, 2021
Drugs in the Pipeline Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer By Brian Park, PharmD Publish Date April 13, 2021
News FDA Clears Point-of-Care Test for Chlamydia, Gonorrhea By Diana Ernst, RPh Last Modified Date March 31, 2021
Drugs in the Pipeline Continued Benefit Observed With Relugolix Combination Therapy in Uterine Fibroids Trial By Diana Ernst, RPh Publish Date March 24, 2021
Drugs in the Pipeline Improved Overall Survival With Cemiplimab in Cervical Cancer Trial By Brian Park, PharmD Publish Date March 15, 2021
News Robotically Assisted Surgical Device Authorized for Transvaginal Hysterectomy Publish Date March 3, 2021
News Pessary Treatment Successful for Symptomatic Pelvic Organ Prolapse Publish Date February 26, 2021
News Relugolix Combo Therapy Beneficial for Fibroid-Related Menorrhagia Publish Date February 22, 2021
Drugs in the Pipeline Fezolinetant Reduces Vasomotor Symptoms Associated With Menopause By Brian Park, PharmD Publish Date February 19, 2021